As of 4:00pm ET
| -0.05 / -0.81%|
The 5 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 18.00, with a high estimate of 33.00 and a low estimate of 13.00. The median estimate represents a +192.68% increase from the last price of 6.15.
The current consensus among 5 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.